We are live on ! Find out more
SAM

Shell Asset Management Portfolio holdings

AUM $996M
1-Year Est. Return 26.19%
This Fund
S&P 500
This Quarter Est. Return
+13.98%
1 Year Est. Return
+26.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.9B
AUM Growth
+$790M
Cap. Flow
+$530M
Cap. Flow %
18.28%
Top 10 Hldgs %
32.57%
Holding
1,285
New
25
Increased
484
Reduced
690
Closed
18

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$32.5M
2
MSFT icon
Microsoft
MSFT
+$31.2M
3
AAPL icon
Apple
AAPL
+$29.5M
4
AMZN icon
Amazon
AMZN
+$19.7M
5
META icon
Meta Platforms (Facebook)
META
+$14M

Sector Composition

Rank Sector Weight
1 Technology 33.47%
2 Financials 14.34%
3 Consumer Discretionary 11.01%
4 Healthcare 9.23%
5 Industrials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNLI icon
1126
Denali Therapeutics
DNLI
$3.82B
$56K ﹤0.01%
4,009
-447
-10% -$6.29K
GRP.U
1127
DELISTED
Granite Real Estate Investment Trust
GRP.U
$56K ﹤0.01%
1,097
PTCT icon
1128
PTC Therapeutics
PTCT
$6.25B
$56K ﹤0.01%
1,151
-120
-9% -$5.7K
TGB
1129
Trekor Metals
TGB
$2.52B
$56K ﹤0.01%
17,800
DLB icon
1130
Dolby
DLB
$4.97B
$55K ﹤0.01%
746
-82
-10% -$6.14K
IMXI icon
1131
International Money Express
IMXI
$398M
$55K ﹤0.01%
5,420
-5,781
-52% -$66K
APOG icon
1132
Apogee Enterprises
APOG
$873M
$54K ﹤0.01%
1,326
-149
-10% -$6.15K
ARIS
1133
Aris Mining
ARIS
$2.99B
$54K ﹤0.01%
8,099
+554
+7% +$3.29K
CPF icon
1134
Central Pacific Financial
CPF
$1.02B
$54K ﹤0.01%
1,939
-4,489
-70% -$118K
BCE icon
1135
BCE
BCE
$20.3B
$53K ﹤0.01%
2,376
-151
-6% -$3.3K
RARE icon
1136
Ultragenyx Pharmaceutical
RARE
$2.56B
$53K ﹤0.01%
1,453
-694
-32% -$25K
RVMD icon
1137
Revolution Medicines
RVMD
$39.1B
$53K ﹤0.01%
1,433
-152
-10% -$5.84K
ECPG icon
1138
Encore Capital Group
ECPG
$2.06B
$52K ﹤0.01%
1,353
-149
-10% -$5.4K
HOUS
1139
DELISTED
Anywhere Real Estate
HOUS
$52K ﹤0.01%
14,316
-10,954
-43% -$38.2K
TUYA
1140
Tuya Inc
TUYA
$1.02B
$52K ﹤0.01%
22,709
BBUC
1141
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.55B
$51K ﹤0.01%
1,624
+103
+7% +$2.81K
NUVB icon
1142
Nuvation Bio
NUVB
$2.33B
$51K ﹤0.01%
26,137
-2,748
-10% -$5.72K
ROKU icon
1143
Roku
ROKU
$21.3B
$51K ﹤0.01%
581
-236
-29% -$16.5K
MYE icon
1144
Myers Industries
MYE
$1.26B
$50K ﹤0.01%
3,425
-2,309
-40% -$28.1K
SRPT icon
1145
Sarepta Therapeutics
SRPT
$1.63B
$50K ﹤0.01%
2,934
-628
-18% -$26.8K
TFIN icon
1146
Triumph Financial Inc
TFIN
$1.84B
$50K ﹤0.01%
910
-101
-10% -$5.62K
AVA icon
1147
Avista
AVA
$3.46B
$49K ﹤0.01%
1,298
-136
-9% -$5.36K
CYH icon
1148
Community Health Systems
CYH
$393M
$49K ﹤0.01%
14,415
-9,528
-40% -$30.6K
ERIE icon
1149
Erie Indemnity
ERIE
$12.7B
$49K ﹤0.01%
141
+57
+68% +$21.1K
OPK icon
1150
Opko Health
OPK
$1.25B
$49K ﹤0.01%
37,028
-3,969
-10% -$5.43K

Similar funds

Shell Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Shell Asset Management held 1,285 positions worth $2.9B, up 37% from $2.11B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Shell Asset Management deployed $530M of net new capital in Q2 2025, opening 25 new positions and adding to 484 existing holdings. Its largest new stake was Globus Medical: 7,947 shares worth $469K.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Celestica, an estimated $2.56M trimmed.

  • Shell Asset Management's largest Q2 2025 buy was Globus Medical: 7,947 shares worth $469K.
  • Shell Asset Management added most to NVIDIA in Q2 2025, an estimated $32.5M increase.
  • Shell Asset Management's biggest Q2 2025 reduction was Celestica, cutting an estimated $2.56M.
  • Shell Asset Management fully exited Discover Financial Services in Q2 2025, selling an estimated $3.74M.
  • Shell Asset Management's ten largest holdings make up 33% of its $2.9B portfolio in Q2 2025.
  • Shell Asset Management opened 25 new positions and closed 18 in Q2 2025.
  • Shell Asset Management's portfolio value rose 37% quarter-over-quarter to $2.9B.

Based on Shell Asset Management's 13F filing for Q2 2025, filed 23 Jul 2025.